Buy Grifulvin V

Grifulvin V

What is Grifulvin V?

Grifulvin V is a prescription antifungal medication that contains the active ingredient griseofulvin. It is supplied as a 250 mg pill and is used to treat fungal infections of the skin, hair, and nails caused by dermatophytes. In Hong Kong, griseofulvin-containing products are regulated under the Pharmacy and Poisons Ordinance and require a medical prescription. The medication is classified as an oral systemic antifungal.

How Grifulvin V Works in the Body

Griseofulvin interferes with the ability of dermatophyte fungi to grow and divide. After oral absorption, the drug is distributed to keratin-rich tissues such as the epidermis, hair shafts, and nails. It binds to fungal microtubules, disrupting mitosis and preventing the fungus from replicating. Because griseofulvin accumulates in keratin, it remains at the site of infection for several weeks, allowing the infected tissue to be replaced by new, fungus-free growth. Onset of action typically occurs within a few days, but full clinical improvement may require several weeks of therapy.

Conditions Treated by Grifulvin V

Grifulvin V is approved in Hong Kong for the treatment of dermatophytosis, including:

• Tinea corporis (ringworm of the body)
• Tinea cruris (jock itch)
• Tinea pedis (athlete’s foot)
• Tinea capitis (scalp ringworm)
• Onychomycosis of the fingernails or toenails caused by dermatophytes

These infections are caused by fungi that invade the outer layers of skin, hair, or nails. Griseofulvin’s ability to concentrate in keratin makes it especially useful for these conditions.

Patient Suitability and Contraindications

Who Should Use Grifulvin V?

• Adults with confirmed dermatophyte infection of skin, hair, or nails
• Patients who can adhere to a prolonged treatment course (often 2-12 weeks)

Absolute Contraindications

• Known hypersensitivity to griseofulvin or any component of the pill
• Pregnancy (griseofulvin is classified as a Category C drug; it is generally avoided because of potential fetal risk)
• Severe liver disease (griseofulvin is metabolized by the liver and can worsen hepatic impairment)

Relative Contraindications / Cautions

• Mild to moderate liver dysfunction - dose may need adjustment and liver function should be monitored
• Use in children under 6 years of age - safety data are limited; pediatric dosing requires specialist guidance
• Concomitant use of drugs that strongly induce or inhibit hepatic enzymes (see interaction section)

Safety Profile: Side Effects and Interactions

Common Side Effects

• Headache
• Nausea or abdominal discomfort
• Dizziness
• Photosensitivity (increased sensitivity to sunlight)
• Mild rash

These effects are usually transient and resolve without medical intervention. Patients should protect their skin from direct sun exposure and use sunscreen while on therapy.

Serious Adverse Events

• Hepatotoxicity (elevated liver enzymes, jaundice) - requires immediate medical evaluation
• Hematologic abnormalities such as neutropenia or thrombocytopenia - rare but serious
• Severe skin reactions (e.g., Stevens-Johnson syndrome) - seek emergency care if a widespread rash develops

Drug Interactions

Major Interactions

• Warfarin - griseofulvin may increase anticoagulant effect; INR should be monitored closely.
• Oral contraceptives - efficacy may be reduced, increasing the risk of unintended pregnancy; an alternative or additional non-hormonal method is advised.

Moderate Interactions

• CYP450 inducers (e.g., rifampin, carbamazepine, phenytoin) - may lower griseofulvin plasma levels, reducing effectiveness.
• CYP450 inhibitors (e.g., erythromycin, azole antifungals) - may raise griseofulvin concentrations, increasing toxicity risk.

Food and Lifestyle Interactions

• Griseofulvin absorption is enhanced when taken with a high-fat meal; patients are usually advised to ingest the pill with food.
• Because of photosensitivity, avoid prolonged sun exposure, tanning beds, and use protective clothing and broad-spectrum sunscreen.
• Alcohol does not have a direct interaction, but excessive intake can exacerbate liver stress.

If a patient is taking other medications, supplements, or herbal products, they should inform their healthcare provider before starting Grifulvin V.

How to Take Grifulvin V

• Standard adult dosing: 250 mg taken orally once daily with a fatty meal for mild dermatophyte infections.
• Moderate to severe infections (e.g., extensive tinea corporis or onychomycosis): the prescriber may increase the regimen to 250 mg twice daily (total 500 mg per day). The 250 mg tablet can be taken twice, respecting the prescribed schedule.

Special Populations

• Renal impairment: No dose adjustment is required for mild to moderate renal dysfunction, but severe impairment should be evaluated by a clinician.
• Hepatic impairment: Start with the lowest effective dose (250 mg once daily) and monitor liver function tests regularly.
• Elderly: Consider starting at 250 mg once daily and adjust based on tolerability.

Administration Tips

• Swallow the pill whole with a glass of water; do not crush or chew.
• Take the medication consistently at the same time each day to maintain stable blood levels.

Missed Dose

• If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.

Overdose

• Symptoms may include severe nausea, vomiting, abdominal pain, and dizziness. Seek emergency medical attention; supportive care is the mainstay of treatment.

Discontinuation

• Griseofulvin does not typically require tapering. However, abrupt cessation should be discussed with a clinician if the infection has not fully resolved, as premature discontinuation can lead to relapse.

Monitoring and Follow-Up

• Liver function tests (ALT, AST, bilirubin): baseline and every 4-6 weeks during prolonged therapy.
• Complete blood count: baseline and periodic monitoring if therapy exceeds 4 weeks, especially in patients with pre-existing hematologic concerns.
• Clinical assessment: patients should report any new rash, jaundice, or persistent gastrointestinal symptoms promptly.

Regular follow-up appointments enable the prescriber to assess treatment response and adjust dosing if needed.

Storage and Handling

• Store Grifulvin V tablets at room temperature, away from excessive heat, moisture, and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use the medication after the expiration date printed on the packaging.
• Dispose of unused tablets according to local pharmacy or hazardous waste guidelines.

Medication-Specific Glossary

Microtubule

A structural component of fungal cells that forms the spindle apparatus during cell division; griseofulvin binds to these structures, halting mitosis.

Photosensitivity

An increased susceptibility of the skin to ultraviolet radiation, leading to sunburn-like reactions; a known side effect of griseofulvin.

Hepatotoxicity

Chemical injury to the liver that may manifest as elevated liver enzymes or jaundice; requires monitoring during griseofulvin therapy.

Medical Disclaimer

This article provides educational information about Grifulvin V and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.